Status:
COMPLETED
Aligning Patient Preferences: a Role Offering Alzheimer's Patients, Caregivers, and Healthcare Providers Education and Support
Lead Sponsor:
Indiana University
Collaborating Sponsors:
National Institute on Aging (NIA)
Hebrew SeniorLife
Conditions:
Alzheimer Disease
Dementia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Nursing home (NH) patients with Alzheimer's disease and related dementias often receive unwanted, burdensome treatments such as hospitalization. Advance care planning (ACP) is a key strategy to suppor...
Detailed Description
A significant number of patients with Alzheimer's disease or related dementia diagnoses will be cared for in nursing homes near the end of life. Unfortunately, many of these patients experience unwant...
Eligibility Criteria
Inclusion
- Facilities are owned by NH corporate partners
- Facilities are Medicare/Medicaid-certified
- Facilities have an electronic medical records system
- Minimum bedsize of 50 or more;
- At least 50% long-stay as defined by a length of stay of 100 days or longer.
Exclusion
- Problematic or unstable facilities will be removed in consultation with NH corporate leaders prior to randomization
Key Trial Info
Start Date :
February 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2022
Estimated Enrollment :
47396 Patients enrolled
Trial Details
Trial ID
NCT03323502
Start Date
February 1 2020
End Date
August 31 2022
Last Update
December 11 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Miller's Merry Manor
Warsaw, Indiana, United States, 46580
2
Signature HealthCARE LLC
Louisville, Kentucky, United States, 40299